--- title: Need for stricter compliance during COVID-19 as fraudulent products flood the markets description: Safety and protection for health have been on the rise like never before, especially since the Covid-19 Pandemic. The pharmaceutical industry is facing the --- +44 203 097 1597 [info@cosmotrace.com](mailto:info@cosmotrace.com) - - - - [![Cosmotrace](https://blog.cosmotrace.com/hs-fs/hubfs/raw_assets/public/CosmoTrace_Oct2021/images/cosmotrace-2.png?width=630&height=209&name=cosmotrace-2.png "Cosmotrace")](https://www.cosmotrace.com/) - [Home](https://www.cosmotrace.com/) - [About Us](https://www.cosmotrace.com/about-us/) - [Careers](https://www.cosmotrace.com/pages/careers/) - [Services](https://www.cosmotrace.com/our-services/) - Compliance Focused - [Misalignment Exceptions Management (US DSCSA)](https://www.cosmotrace.com/our-services/misalignment-exceptions-management-us-dscsa/) - [EU Alert Management](https://www.cosmotrace.com/our-services/eu-alert-management/) - [Middle East Serialization Consulting](https://www.cosmotrace.com/our-services/middle-east-serialization-consulting/) - [China Reporting Services](https://www.cosmotrace.com/our-services/china-reporting-services/) - Business Operations Focused - [Master Data Management](https://www.cosmotrace.com/our-services/master-data-management/) - [Trade Partner Onboarding](https://www.cosmotrace.com/our-services/trade-partner-onboarding/) - [Level 4 System Validation](https://www.cosmotrace.com/our-services/level-4-system-validation/) - [Serialization System Health Check](https://www.cosmotrace.com/our-services/serialization-system-health-check/) - Business Processes Outsourcing - [Managed Services CoE](https://www.cosmotrace.com/our-services/managed-services-coe/) - [US DSCSA Ti Digitization](https://www.cosmotrace.com/our-services/us-dscsa-ti-digitization/) - [Our Solutions](https://www.cosmotrace.com/solutions/) - [Traceware](https://www.cosmotrace.com/solutions/traceware/) - [nTrack](https://www.cosmotrace.com/solutions/ntrack/) - [Clients](https://www.cosmotrace.com/clients/) - [Blog](https://www.cosmotrace.com/blog/) - [Serialization](https://www.cosmotrace.com/blog/serialization) - [Digital](https://www.cosmotrace.com/blog/digital) - [News](https://www.cosmotrace.com/blog/news/) - [Contact](https://www.cosmotrace.com/contact-us/) - - - - - [Home](https://www.cosmotrace.com/) - [About Us](https://www.cosmotrace.com/about-us/) - [Careers](https://www.cosmotrace.com/pages/careers/) - [Services](https://www.cosmotrace.com/our-services/) - Compliance Focused - [Misalignment Exceptions Management (US DSCSA)](https://www.cosmotrace.com/our-services/misalignment-exceptions-management-us-dscsa/) - [EU Alert Management](https://www.cosmotrace.com/our-services/eu-alert-management/) - [Middle East Serialization Consulting](https://www.cosmotrace.com/our-services/middle-east-serialization-consulting/) - [China Reporting Services](https://www.cosmotrace.com/our-services/china-reporting-services/) - Business Operations Focused - [Master Data Management](https://www.cosmotrace.com/our-services/master-data-management/) - [Trade Partner Onboarding](https://www.cosmotrace.com/our-services/trade-partner-onboarding/) - [Level 4 System Validation](https://www.cosmotrace.com/our-services/level-4-system-validation/) - [Serialization System Health Check](https://www.cosmotrace.com/our-services/serialization-system-health-check/) - Business Processes Outsourcing - [Managed Services CoE](https://www.cosmotrace.com/our-services/managed-services-coe/) - [US DSCSA Ti Digitization](https://www.cosmotrace.com/our-services/us-dscsa-ti-digitization/) - [Our Solutions](https://www.cosmotrace.com/solutions/) - [Traceware](https://www.cosmotrace.com/solutions/traceware/) - [nTrack](https://www.cosmotrace.com/solutions/ntrack/) - [Clients](https://www.cosmotrace.com/clients/) - [Blog](https://www.cosmotrace.com/blog/) - [Serialization](https://www.cosmotrace.com/blog/serialization) - [Digital](https://www.cosmotrace.com/blog/digital) - [News](https://www.cosmotrace.com/blog/news/) - [Contact](https://www.cosmotrace.com/contact-us/) - - - - # Need for stricter compliance during COVID-19 as fraudulent products flood the markets Jul 3, 2020 | [Serialization](https://blog.cosmotrace.com/serialization/tag/serialization), [Pharmaceutical](https://blog.cosmotrace.com/serialization/tag/pharmaceutical), [Counterfeit](https://blog.cosmotrace.com/serialization/tag/counterfeit), [Covid-19](https://blog.cosmotrace.com/serialization/tag/covid-19) Safety and protection for health have been on the rise like never before, especially since the Covid-19 Pandemic. The pharmaceutical industry is facing the pressure to meet the demands for measures to be put in place to safeguard the public and build immunity against the virus. To meet the demands for test supplies, equipment, and medicines remain a priority, fraudulent products continue to flood the markets during COVID-19. These fake commodities pose a real threat to examiners and consumers alike. Public health is at greater risk as counterfeit goods often don’t meet the industry’s set quality standards. The danger in such cases is usually because of inaccurate/unclear labeling or inappropriate quantities/ lack of ingredients. The Pandemic has also led to showing an increase in people turning to the internet to self-diagnose their conditions and self-prescribing medication by purchasing products online. Through observations, it is generally noted that those who buy counterfeit goods believe they are protected against the virus, when they are in reality, unprotected, or made further vulnerable because of the content in fake medicines. According to the latest report (June 29th, 2020) from the International Hologram Manufacturers Association (IHMA), their most recent study by a community media platform revealed that 20% of products sold on e-commerce are counterfeit. The IHMA advises brand owners and product manufacturers to be more vigilant in combating threats and strategize for advanced authentication and verification technologies to protect brands. Greater importance needs to be given to the critical need for further developing anti-counterfeiting technologies. #### Search #### Recent Posts - [Egypt’s Pharmaceutical Track and Trace - From 2019 Pilot to 2025 Nationwide Mandate](https://blog.cosmotrace.com/serialization/egypt-pharma-traceability-2025-mandate) - [Algeria’s 2027 Pharmaceutical Serialization & Aggregation](https://blog.cosmotrace.com/serialization/algeria-2027-pharmaceutical-serialization-aggregation) - [Serialization and Traceability in the Middle East: Navigating a Complex Compliance Landscape](https://blog.cosmotrace.com/serialization/middle-east-serialization-traceability-compliance) - [Sri Lanka Extends Barcode Grace Period for Medicines: What MAHs Need to Know](https://blog.cosmotrace.com/serialization/sri-lanka-barcode-grace-period-extension) - [DSCSA Enforcement Timeline: What Trading Partners Need to Know in 2025](https://blog.cosmotrace.com/serialization/dscsa-enforcement-timeline-2025) - - - - © 2020 CosmoTrace - part of ZeeInx Group